NEW YORK (360Dx) – A team led by researchers at Arizona State University's Biodesign Institute has developed a mass spec-based test for diagnosing and monitoring active tuberculosis.
Detailed in a study published this week in Proceedings of the National Academy of Sciences, the test uses MALDI mass spec combined with an antibody-based target enrichment device to measure the levels of two Mycobacterium tuberculosis peptides.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
